Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.

Biotechnology

Nurix

Arthur T. Sands

Evan Lewis

Zarmina Wartena

Sarah Whelan

Praveen Srivastava

Paula G. O’Connor

Elizabeth Bosch

Eren Demirhan

Hans van Houte

Christine Ring

Eric Schlezinger

Buckley Kohlhauff

Seema P. Rogers

Christopher B. Phelps

Gwenn M. Hansen

Leadership Team

Research and Development

Clinical Operations

��

Teams at Nurix

Leadership Team

Research and Development

Clinical Operations

��������

Teams at Nurix

Leadership Team

Research and Development

Clinical Operations

��